Guidance on applications for drug clinical trials under the interim order: Overview
Guidance document provides applicants seeking authorization to conduct COVID-19 drug clinical trials specifically around the applications guidelines and process.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Guidance on applications for drug clinical trials under the interim order: OverviewHTMLEnglish publication HTML
-
Guidance on applications for drug clinical trials under the interim order: OverviewHTMLFrench publication HTML
-
Guidance on applications for drug clinical trials under the interim order: General requirementsHTMLEnglish publication HTML
-
Guidance on applications for drug clinical trials under the interim order: Who to contactHTMLEnglish publication HTML
Similar records